| Date Checked | 2026-02-19 22:15:27 |
|---|
| Graham Number | (PB)107.93 vs (PE)68.75 |
|---|
| Over / Under Value Percentage | 84.88% vs 121.19% |
|---|
| Dividend Yield | 2.01% |
|---|
| Dividend Date | 2026-03-31 |
|---|
| Symbol | BDX |
|---|
| AssetType | Common Stock |
|---|
| Name | Becton Dickinson and Company |
|---|
| Description | Becton, Dickinson and Company (BDX) is a leading American multinational medical technology company dedicated to advancing healthcare through the innovative development and manufacture of essential medical devices, instrument systems, and reagents. With a robust and diverse product portfolio that caters to a wide range of diagnostic and therapeutic applications, BDX has established a significant presence in the global healthcare landscape. The company's steadfast commitment to research and development positions it at the forefront of emerging medical technology trends, enhancing its ability to deliver next-generation healthcare solutions while optimizing operational efficiency across various healthcare sectors. |
|---|
| CIK | 10795 |
|---|
| Exchange | NYSE |
|---|
| Currency | USD |
|---|
| Country | USA |
|---|
| Sector | HEALTHCARE |
|---|
| Industry | MEDICAL INSTRUMENTS & SUPPLIES |
|---|
| Address | 1 BECTON DRIVE, FRANKLIN LAKES, NJ, UNITED STATES, 07417-1880 |
|---|
| OfficialSite | https://www.bd.com |
|---|
| FiscalYearEnd | September |
|---|
| LatestQuarter | 2025-09-30 |
|---|
| MarketCapitalization | 59836400000 |
|---|
| EBITDA | 6222000000 |
|---|
| PERatio | 36.09 |
|---|
| PEGRatio | 0.946 |
|---|
| BookValue | 88.96 |
|---|
| DividendPerShare | 4.16 |
|---|
| EPS | 5.82 |
|---|
| RevenuePerShareTTM | 75.93 |
|---|
| ProfitMargin | 0.0768 |
|---|
| OperatingMarginTTM | 0.179 |
|---|
| ReturnOnAssetsTTM | 0.0417 |
|---|
| ReturnOnEquityTTM | 0.0654 |
|---|
| RevenueTTM | 21839999000 |
|---|
| GrossProfitTTM | 10359000000 |
|---|
| DilutedEPSTTM | 5.82 |
|---|
| QuarterlyEarningsGrowthYOY | 0.252 |
|---|
| QuarterlyRevenueGrowthYOY | 0.083 |
|---|
| AnalystTargetPrice | 211.92 |
|---|
| AnalystRatingStrongBuy | 2 |
|---|
| AnalystRatingBuy | 3 |
|---|
| AnalystRatingHold | 9 |
|---|
| AnalystRatingSell | 0 |
|---|
| AnalystRatingStrongSell | 0 |
|---|
| TrailingPE | 36.09 |
|---|
| ForwardPE | 14.1 |
|---|
| PriceToSalesRatioTTM | 2.74 |
|---|
| PriceToBookRatio | 2.354 |
|---|
| EVToRevenue | 3.586 |
|---|
| EVToEBITDA | 15.8 |
|---|
| Beta | 0.285 |
|---|
| 52WeekHigh | 231.4 |
|---|
| 52WeekLow | 160.6 |
|---|
| 50DayMovingAverage | 199.55 |
|---|
| 200DayMovingAverage | 187.17 |
|---|
| SharesOutstanding | 284633000 |
|---|
| SharesFloat | 284691000 |
|---|
| PercentInsiders | 0.386 |
|---|
| PercentInstitutions | 95.589 |
|---|
| ExDividendDate | 2026-03-10 |
|---|
| dateChecked | 2026-02-19 22:15:27 |
|---|
| fresh | 1 |
|---|